This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Clozapine Augmentation With Aripiprazole for Negative Symptoms

Laura A. Clarke, MD; Jean-Pierre Lindenmayer, MD; and Saurabh Kaushik, MD

Published: April 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Clozapine has long been viewed as the gold standard used for schizophrenia patients refractory to treatment with typical and atypical antipsychotics. Although clozapine is highly effective, a number of patients are also treatment refractory or only partially responsive to clozapine. For these patients, augmentation strategies can be considered after a careful evaluation of risk versus benefit to avoid potential drug interactions.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 67

Quick Links: